BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30111273)

  • 21. [Does the heart desire mountain air? Impact of altitude on cardiovascular risk].
    Faeh D
    Praxis (Bern 1994); 2011 Sep; 100(18):1107-13. PubMed ID: 21932199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D and atherosclerosis.
    Menezes AR; Lamb MC; Lavie CJ; DiNicolantonio JJ
    Curr Opin Cardiol; 2014 Nov; 29(6):571-7. PubMed ID: 25144342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.
    Chrysant SG; Chrysant GS
    Expert Rev Cardiovasc Ther; 2018 Aug; 16(8):559-565. PubMed ID: 29979619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vitamin D in cardiovascular health.
    Reddy Vanga S; Good M; Howard PA; Vacek JL
    Am J Cardiol; 2010 Sep; 106(6):798-805. PubMed ID: 20816120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin in Primary Prevention of Myocardial Infarction/Angina and Stroke in Hypertensive Patients.
    Almas A; Ghazni MS; Hashmani S; Mushtaq Z
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):574. PubMed ID: 29950269
    [No Abstract]   [Full Text] [Related]  

  • 26. The polypill in the primary prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Fundam Clin Pharmacol; 2010 Feb; 24(1):29-35. PubMed ID: 20002198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing the global burden of stroke: INTERSTROKE.
    Tu JV
    Lancet; 2010 Jul; 376(9735):74-5. PubMed ID: 20561674
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammation and cardiovascular disease mechanisms.
    Libby P
    Am J Clin Nutr; 2006 Feb; 83(2):456S-460S. PubMed ID: 16470012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
    Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ
    Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [WHO/ISH 2003].
    Takeda K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():556-61. PubMed ID: 16981590
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.
    Millan J; Pintó X; Brea A; Blasco M; Hernández-Mijares A; Ascaso J; Diaz A; Mantilla T; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(1):30-35. PubMed ID: 29395493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roles of angiopoietin-like protein 2 (Angptl2) in chronic inflammation and atherosclerotic diseases].
    Oike Y
    Nihon Rinsho; 2011 Jan; 69(1):163-7. PubMed ID: 21226278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis-associated arterial disease.
    Desbois AC; Cacoub P
    Ann Vasc Surg; 2013 Oct; 27(7):996-1005. PubMed ID: 23850313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is folic acid supplementation useful for chronic kidney disease?
    Bravo-Soto GA; Madrid T
    Medwave; 2016 Nov; 16(Suppl5):e6591. PubMed ID: 27858927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Links between Vitamin D Deficiency and Cardiovascular Diseases.
    Mozos I; Marginean O
    Biomed Res Int; 2015; 2015():109275. PubMed ID: 26000280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutrition and cardiovascular disease.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2499-506. PubMed ID: 17954523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factor management: a practice guide.
    Perk J
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S24-8. PubMed ID: 19675433
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vitamin D deficiency and cardiovascular diseases].
    Ciccone MM; Zito A; Dentamaro I; Vestito D; Scicchitano P; Iacoviello M; De Pergola G; Devito F
    G Ital Cardiol (Rome); 2015 Jan; 16(1):16-20. PubMed ID: 25689747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charting new territory by simulated modeling of a clinical trial.
    Tuttle KR
    Clin J Am Soc Nephrol; 2010 May; 5(5):750-2. PubMed ID: 20360306
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
    Bajuk Studen K; Jensterle Sever M; Pfeifer M
    Front Horm Res; 2013; 40():64-82. PubMed ID: 24002406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.